Cargando…
Biotinidase Deficiency: Prevalence, Impact And Management Strategies
Biotinidase deficiency is an autosomal recessive inherited neurocutaneous disorder. Clinically untreated patients with BD can present with variable neurological and dermatological signs, such as seizures, hypotonia, feeding problems, developmental delay, hearing loss, optic atrophy ataxia, alopecia,...
Autores principales: | Canda, Ebru, Kalkan Uçar, Sema, Çoker, Mahmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211084/ https://www.ncbi.nlm.nih.gov/pubmed/32440248 http://dx.doi.org/10.2147/PHMT.S198656 |
Ejemplares similares
-
Two siblings with galactose mutarotase deficiency: Clinical differences
por: Yazici, Havva, et al.
Publicado: (2021) -
A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate
por: Köse, Melis, et al.
Publicado: (2017) -
Tetrahydrobiopterin deficiencies: Lesson from clinical experience
por: Bozaci, Ayse Ergul, et al.
Publicado: (2021) -
Management of anesthesia in biotinidase deficiency
por: Goktas, Ugur, et al.
Publicado: (2014) -
COVID-19 and Vaccination Status in Lysosomal Storage Diseases: A Single-Center Experience
por: Yoldaş Çelik, Merve, et al.
Publicado: (2023)